Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.35
-$0.015-0.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.07% | -3.33% | -7.68% | -0.10% | -4.36% |
| Total Other Revenue | 19.92% | -- | -10.57% | 24.17% | -27.48% |
| Total Revenue | 7.14% | -3.33% | -7.72% | 0.08% | -4.53% |
| Cost of Revenue | 6.20% | -1.32% | -6.01% | 4.45% | -1.08% |
| Gross Profit | 12.54% | -10.41% | -18.05% | -19.29% | -20.33% |
| SG&A Expenses | 15.91% | -13.31% | 2.71% | -17.83% | -12.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 672.97% | 156.09% | 528.22% | -68.73% | -28.64% |
| Total Operating Expenses | 7.58% | -2.75% | -3.86% | 1.58% | -2.52% |
| Operating Income | -4.03% | -8.48% | -185.44% | -22.16% | -37.51% |
| Income Before Tax | 10.76% | -10.21% | -211.70% | -35.58% | -36.15% |
| Income Tax Expenses | 0.29% | -12.34% | -501.12% | -26.19% | -39.47% |
| Earnings from Continuing Operations | 13.08% | -9.76% | -187.65% | -37.57% | -35.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 47.21% | 51.54% | 47.26% | 55.01% | 13.25% |
| Net Income | 17.65% | -8.19% | -222.79% | -37.09% | -36.60% |
| EBIT | -4.03% | -8.48% | -185.44% | -22.16% | -37.51% |
| EBITDA | -4.32% | -8.70% | -130.99% | -17.91% | -33.94% |
| EPS Basic | 17.73% | -8.17% | -223.11% | -37.02% | -36.62% |
| Normalized Basic EPS | -11.76% | -7.61% | -238.02% | -28.08% | -36.18% |
| EPS Diluted | 17.73% | -8.17% | -223.11% | -37.02% | -36.62% |
| Normalized Diluted EPS | -11.76% | -7.61% | -238.02% | -28.08% | -36.18% |
| Average Basic Shares Outstanding | -0.06% | -0.01% | 0.07% | 0.01% | -0.03% |
| Average Diluted Shares Outstanding | -0.06% | -0.01% | 0.07% | 0.01% | -0.03% |
| Dividend Per Share | 0.18% | -- | -46.38% | -- | -- |
| Payout Ratio | -0.51% | 0.17% | -6.56% | 0.59% | 0.56% |